SubHero Banner

COVID-19 Vaccines – FDA advisors discuss Pfizer/BioNTech’s vaccine for patients 5 to < 12 years

October 26, 2021 - The FDA convened a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting to discuss expanding the emergency use authorization (EUA) for Pfizer/BioNTech’s COVID-19 vaccine to include children between 5 and < 12 years of age.

Download PDF